providence medical research center

Making Spokane a RESEARCH CENTER

Providence medical research eyes expanding capabilities, attracting talent.

Dr. Katherine Tuttle, medical and scientific director of Providence Medical Research Center here, says the center is on its way to becoming a full-fledged research institute, a path she says will help Spokane attract sought-after medical and research talent and will help Sacred Heart Medical Center emerge as a training hospital. What will make Providence Medical Research a research institute within the next decade is the ability to conduct whats called translational research, Tuttle says. Translational research connects basic research with clinical trials in a continuum, from cellular research on disease to trials in which medications are used on animals to clinical trials on humans, Tuttle says. Such a continuum can spark additional basic research, creating a rich research environment, she says. Currently, the center is involved in about 300 different research studies, ranging from sleep studies to orthopedic studies. Most of those are clinical studies, a few involve basic research, and some are considered humanitarian studies of specialized therapies because they address less common diseases. Tuttle says she believes the center is the largest research operation in the Seattle-based nonprofit Providence Health & Services Network, which operates 26 hospitals, more than 35 nonacute-care facilities, physicians clinics, and other operations in five Pacific Northwest states. Sacred Heart is among the hospitals under that umbrella. Tuttle already is participating in translational research, conducted in part at the University of Washington, where she also is a full professor. That research is in a field called proteomics, which seeks new ways to measure the results of clinical research. She says most measures of how successful a treatment is involve how many patients die after receiving a treatment or how long patients live after they receive a treatment. That means with chronic diseases, it can be many years before a trial can be evaluated fully, she says. Proteomics instead seeks to identify disease-specific biological markers on cells that can be measured before and after a treatment to determine the treatments effectiveness. Tuttle says shes helping to identify disease biomarkers in the research shes involved with at UW, where a full continuum of research, including animal trials, can be done. The Spokane center currently doesnt have the capability to conduct animal trials, she says. Tuttle says such markers could significantly advance research here into diseases such as diabetic kidney disease. Biomarker development will be very important, she says. Early results from that research at UW have been promising, but her colleagues there are seeking additional money to continue the work, Tuttle says. Such research has a much broader focus than the focus the Spokane center had when it began. When it opened as the Heart Institute in 1991, the center first focused on cardiovascular research and public education. Sacred Heart took over operation of the Heart Institute in 2004 and eventually changed its name to the Providence Medical Research Center. Tuttle says that has been a huge benefit to the center. By becoming part of the hospital, the center ended up with a greater financial safety net and the resources to grow, she says. Its budget has about tripled since Sacred Heart took it over, and because it took on a far broader mission than just cardiovascular research, it moved into far more research areas. The program creates its own gravity to pull additional projects in and contributes a lot to the development of Sacred Heart as a regional center for medical expertise in a number of fields, Tuttle says. Its a great recruitment tool for sophisticated specialists, who often are attracted to positions at facilities where they can continue research, Tuttle says. We say, Of course, if you bring your NIH (National Institutes of Health) study here we can support it. Tuttle has created a lot of that gravitational pull, drawing attention to the center through national appointments she holds, including one as chairwoman of the National Diabetes Education Program Health Care Professional Work Group, and through original research that brings recognition to the center here. Tuttle says she believes that Sacred Heart will emerge as a training hospital here in part because of the growing research program. This is going to be the main teaching hospital here, she says. She says the hiring of eight faculty members for an expansion of the University of Washington medical school program, called WWAMI, at the Riverpoint Higher Education Campus also will help attract talent to the region. Greater focus Research has become more focused as research dollars have diminished, Tuttle says. With less research money available from the U.S. governments National Institutes of Health, and fewer dollars available from foundations and medical companies, the studies being done today increasingly are those that will have the greatest impact, a trend thats ultimately good, she says. Lean times stimulate productivity and creativity, as long as you dont starve, she says. The Providence center does some privately funded research, which can lead to opportunities for better patient care here, but companies are becoming more conservative with their research dollars, Tuttle says. One such study under way here is sponsored by Sirtex Technology Pty. Ltd., of Australia. Dr. David Liu, a Spokane interventional radiologist, is participating in a pilot study of treatment for metastatic liver tumors that involves a method of delivering a combination of chemotherapy and radiation therapy through a technology called microspheres, Tuttle says. That treatment could improve quality of life for patients here, she says. Federal dollars are most available for original, translational research, making it more difficult for centers that arent equipped to do such research to compete for money. The opportunities to do translational studies are limited here because facilities dont have the ability to conduct all components of that research, Tuttle says. Tuttle has been working to change that. She says that if the Institute for Systems Medicine, a planned biomedical research institute, is fully funded, and the WWAMI program is successful here, the Providence Medical Research Center will become a place where translational research can take place. Although she increasingly takes on national appointments that give her the opportunity to be directly involved in shaping public health policy, its important to her to remain connected to primary research, too, Tuttle says. Im really excited about research and I love collaborating, she says. Scientific people want to make a difference. Contact Jeanne Gustafson at (509) 344-1264 or via e-mail at [email protected].

Aslin-Finch makes bold moves

Restricted Content

You must have JavaScript enabled to enjoy a limited number of articles over the next 30 days.

Subscribe today to our free E-Newsletters!

Featured Poll

Where do you listen to podcasts, popular articles.

The Chalet Restaurant changes hands on South Hill

Big hopes for big cats: Cat Tales envisions relocation

Excelsior proposes comprehensive wellness village at Indian Trail campus

Saltese Creek development to add about 400 units in Valley

The Collective Effort

• Providence Library Services

Home > REGIONAL_RESEARCH > WA_RESEARCH > PMRC_SPOKANE

Providence Medical Research Center - Spokane

Submissions from 2024 2024.

Comparison of anticoagulation vs mechanical thrombectomy for the treatment of iliofemoral deep vein thrombosis. , Steven Abramowitz, Abdullah Shaikh, Hamid Mojibian, Nicolas J Mouawad, Matthew C Bunte, Edvard Skripochnik, Jonathan Lindquist, Fakhir Elmasri, Bhavraj Khalsa, Ambarish Bhat, James Nguyen, Neil Shah, Sonya S Noor, Douglas Murrey, Sagar Gandhi, Adam Raskin, Jonathan Schor, and David J Dexter

Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial. , Stefan R Bornstein, Dick de Zeeuw, Hiddo J L Heerspink, Friedrich Schulze, Lisa Cronin, Arne Wenz, Katherine Tuttle, Samy Hadjadj, and Peter Rossing

Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study. , Alexandra J Borst, Whitney Eng, Morgan Griffin, Kiersten W Ricci, Elissa Engel, Denise M Adams, Jillian Dayneka, Sally J Cohen-Cutler, Steven M Andreoli, Melinda D Wu, Allison P Wheeler, Kenneth M Heym, Shelley E Crary, Taizo A Nakano, Rachael R Schulte, Bhuvana A Setty, Thomas W McLean, Kristy S Pahl, Stefanos Intzes, Irina Pateva, Max Teitelbaum, Zili Zong, Yimei Li, and Michael R Jeng

The Impact of Moral Injury on Self-reported Work Performance in Hospital Nurses Following the Global Pandemic Surge. , Annette Browning Callis, Trisha Saul, and Ross J Bindler

New and emerging therapies for diabetic kidney disease. , Ricardo Correa-Rotter, Louise J Maple-Brown, Rakesh Sahay, Katherine R Tuttle, and Ifeoma I Ulasi

Perceived Barriers to Patient Mobilization Among Therapy and Nursing Acute Care Staff: A Multi-Site Survey Study. , Elena Crooks, Tiffanie Rampley, Douglas L Weeks, Crystal Billings, Danell Stengem, and Teresa Rangel

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial. , EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial. , EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial. , EMPA-KIDNEY Collaborative Group and Katherine Tuttle

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial. , EMPA-KIDNEY Collaborative Group and Katherine Tuttle

Differences in nutritional profile by chronotype among 12-h day shift and night shift nurses. , Rachel Faulkner, Teresa Rangel, Rebecca Penders, Trisha Saul, Ross Bindler, Lindsey Miller, and Marian Wilson

Healthcare Professional Awareness of Climate Health and an Evidence-based Environmental Stewardship Framework , Patricia Joubert, Rosemary Timmerman, Angie Shemwell, Barbara Ngyuen, and Teresa Rangel

Health Professional Concern for Environment and Behaviors to Protect Climate Health , Mary Jo Kelly, Sarah Johnson, Teresa Rangel, and Gale Springer

Development and Validation of the American Heart Association's PREVENT Equations. , Sadiya S Khan, Kunihiro Matsushita, Yingying Sang, Shoshana H Ballew, Morgan E Grams, Aditya Surapaneni, Michael J Blaha, April P Carson, Alexander R Chang, Elizabeth Ciemins, Alan S Go, Orlando M Gutierrez, Shih-Jen Hwang, Simerjot K Jassal, Csaba P Kovesdy, Donald M Lloyd-Jones, Michael G Shlipak, Latha P Palaniappan, Laurence Sperling, Salim S Virani, Katherine Tuttle, Ian J Neeland, Sheryl L Chow, Janani Rangaswami, Michael J Pencina, Chiadi E Ndumele, Josef Coresh, and Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group

Mind the gap in kidney care: translating what we know into what we do. , Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and World Kidney Day Joint Steering Committee

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD. , Kaitlin J Mayne, Natalie Staplin, David F Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka, Johannes Stegbauer, Parminder K Judge, David Preiss, Jonathan Emberson, Daniele Trinca, Rejive Dayanandan, Ryonfa Lee, John Nolan, Akiko Omata, Jennifer B Green, David Z I Cherney, Lai Seong Hooi, Roberto Pontremoli, Katherine Tuttle, Jennifer S Lees, Patrick B Mark, Simon J Davies, Sibylle J Hauske, Dominik Steubl, Martina Brückmann, Martin J Landray, Colin Baigent, Richard Haynes, William G Herrington, and EMPA-KIDNEY Collaborative Group

Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure. , Jeremy Nicolarsen, James Mudd, and Andrew Coletti

Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE). , Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine Tuttle, and Vlado Perkovic

Association of mental health-related patient reported outcomes with blood pressure in adults and children with primary proteinuric glomerulopathies. , Matthew Schuchman, Tammy M Brady, Dorey A Glenn, Katherine Tuttle, Gabriel Cara-Fuentes, Rebecca V Levy, Agustin Gonzalez-Vicente, Fadhl M Alakwaa, Tarak Srivastava, and Christine B Sethna

Perceived Moral Distress among Patient-facing Healthcare Professionals during the COVID-19 pandemic , Sarah Sumner, Karen Colorafi, and Teresa Rangel

Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today. , Howard Trachtman, Hailey Desmond, Amanda L Williams, Laura H Mariani, Sean Eddy, Wenjun Ju, Laura Barisoni, Heather K Ascani, Wendy R Uhlmann, Cathie Spino, Lawrence B Holzman, John R Sedor, Crystal Gadegbeku, Lalita Subramanian, Chrysta C Lienczewski, Tina Manieri, Scott J Roberts, Debbie S Gipson, Matthias Kretzler, NEPTUNE investigators, and Katherine Tuttle (NEPTUNE investigators)

Second Malignant Neoplasms Following Treatment for Hepatoblastoma: An International Report and Review of the Literature. , Angela Trobaugh-Lotrario, Kenichiro Watanabe, Allison F O'Neill, Bozenna Dembowska-Bagińska, Beate Häberle, Andrew Murphy, Eiso Hiyama, Piotr Czauderna, Rebecka L Meyers, Max Langham, and James Feusner

GLP-1 Receptor Agonists for CKD in Diabetes and Beyond… , Katherine Tuttle

Helio “Aldosterone inhibitor BI 690517 reduced albuminuria when combined with SGLT2 inhibitor” , Katherine Tuttle

Clinical Characteristics and Histopathology in Adults With Focal Segmental Glomerulosclerosis. , Katherine Tuttle, Clint W Abner, Patrick D Walker, Kaijun Wang, Andrew Rava, Jihaeng Heo, and Martin Bunke

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial. , Katherine Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, Maria Luiza Caramori, David Cherney, Lisa Cronin, Hiddo J L Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa Rotter, Arnold Silva, Shimoli V Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, and Peter Rossing

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial. , Katherine R Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, Maria Luiza Caramori, David Cherney, Lisa Cronin, Hiddo J L Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa Rotter, Arnold Silva, Shimoli V Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, Peter Rossing, and ASi in CKD group

Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study. , Chia-Shi Wang, Dorey A Glenn, Margaret Helmuth, Abigail R Smith, Andrew S Bomback, Pietro A Canetta, Gaia M Coppock, Myda Khalid, Katherine Tuttle, Raed Bou-Matar, Larry A Greenbaum, Bruce M Robinson, Lawrence B Holzman, William E Smoyer, Michelle N Rheault, Debbie Gipson, Laura H Mariani, and Cure Glomerulonephropathy (CureGN) Study Consortium

Critical lessons from a pragmatic randomized trial of home-based COVID-19 testing in rural Native American and Latino communities. , Eliza Webber, Sonia Bishop, Paul K Drain, Virgil Dupuis, Lorenzo Garza, Charlie Gregor, Laurie Hassell, Geno Ibarra, Larry Kessler, Linda Ko, Alison Lambert, Victoria Lyon, Carly Rowe, Michael Singleton, Matthew Thompson, Teresa Warne, Wendy Westbroek, and Alexandra Adams

Increasing U.S. Maternal Health Equity Among Immigrant Populations Through Community Engagement. , Maryum Zaidi, Heidi Collins Fantasia, Rebecca Penders, Ainat Koren, and Comfort Enah

Submissions from 2023 2023

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone. , Rajiv Agarwal, Bertram Pitt, Peter Rossing, Stefan D Anker, Gerasimos Filippatos, Luis M Ruilope, Csaba P Kovesdy, Katherine Tuttle, Muthiah Vaduganathan, Christoph Wanner, Sameer Bansilal, Martin Gebel, Amer Joseph, Robert Lawatscheck, and George L Bakris

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. , Rajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, Youssef M K Farag, Robert Toto, Sanjay Kaul, Robert Lawatscheck, Katja Rohwedder, Luis M Ruilope, Peter Rossing, Bertram Pitt, Gerasimos Filippatos, Stefan D Anker, George L Bakris, FIDELIO-DKD and FIGARO-DKD Investigators, and Katherine Tuttle

“Intensifying Diabetes Therapies to Achieve Personalized Treatment Goals” , Radica Alicic

Incidence of chronic kidney disease in prediabetes , Radica Alicic, Ken Daratha, Josh Neumiller, Katherine Tuttle, and See all authors in comments

Author Response to "Insulin Dosing Safety in CKD". , Radica Alicic, Joshua J Neumiller, Rodolfo J Galindo, and Katherine Tuttle

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease. , Radica Alicic, Joshua J Neumiller, and Katherine Tuttle

Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease. , Radica Z Alicic and Joshua J Neumiller

American Society for Gastrointestinal Endoscopy guideline on management of post-liver transplant biliary strictures: methodology and review of evidence. , Stuart K Amateau, Divyanshoo R Kohli, Madhav Desai, Srinath Chinnakotla, M Edwyn Harrison, Jean M Chalhoub, Nayantara Coelho-Prabhu, Sherif E Elhanafi, Nauzer Forbes, Larissa L Fujii-Lau, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly Ruan, Sunil G Sheth, Nikhil R Thiruvengadam, Nirav C Thosani, Bashar J Qumseya, and ASGE Standards of Practice Committee Chair

Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6 , SC Bain, Katherine Tuttle, and See Full List of Authors in Comments

Preventing CHF hospitalizations in patients with dementia , John Beale, Zoe Tartz, Jackson Harley, Tory Starzyk, Matthew Kennedy, and Colleen Zimmermann

Kidney Biopsy Utility: Patient and Clinician Perspectives from the Kidney Precision Medicine Project. , Lauren Bernard, Ashley R Wang, Steven Menez, Joel M Henderson, Ashveena Dighe, Glenda V Roberts, Christine Stutzke, Katherine Tuttle, R Tyler Miller, and Kidney Precision Medicine Project

Orientation materials: Impact of Transitioning from Paper to an Electronic Format , Megan Bowles, Abby Lust, Teresa Rangel, and Tobi Bryan

Identifying Systemic errors in refilling insulin to prevent another hospitalization: An RCA , John Butler, Mikayla Button, Jared Fincher, Rakin Solaiman, and Michael Woodfin

American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence. , James L Buxbaum, Martin Freeman, Stuart K Amateau, Jean M Chalhoub, Aneesa Chowdhury, Nayantara Coelho-Prabhu, Rishi Das, Madhav Desai, Sherif E Elhanafi, Nauzer Forbes, Larissa L Fujii-Lau, Divyanshoo R Kohli, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly H Ruan, Jonathan Sadik, Sunil G Sheth, Nikhil R Thiruvengadam, Nirav C Thosani, Selena Zhou, and Bashar J Qumseya

American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. , James L Buxbaum, Martin Freeman, Stuart K Amateau, Jean M Chalhoub, Nayantara Coelho-Prabhu, Madhav Desai, Sherif E Elhanafi, Nauzer Forbes, Larissa L Fujii-Lau, Divyanshoo R Kohli, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly H Ruan, Sunil G Sheth, Nikhil R Thiruvengadam, Nirav C Thosani, and Bashar J Qumseya

Patient Reported Outcomes Using Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease. , Priscilla C Canals, Alexia G Aguilar, Gregory T Carter, C Miyabe Shields, Andrew Westerkamp, Meg D'Elia, Joy Aldrich, Robert N Moore, Allison T Moore, and Brian J Piper

A quality improvement initiative to bridge gaps in treatment and interprofessional care of chronic kidney disease , DA Cappel, Katherine Tuttle, and See all authors in comments

A Diagnostic Dilemma: QIPS , Ryan Carlisle, Paulina Giacomelli, Kyler Wyer, Julia Nyiro, Nolan Weinstein, and Judy Swanson (Faculty Advisor)

Procedure 25: Bronchoscopy (Perform) , Chong Sherry Cheever

Procedure 26: Bronchoscopy (Assist) , Chong Sherry Cheever

Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network. , Dhruti P Chen, Margaret E Helmuth, Abigail R Smith, Pietro A Canetta, Isabelle Ayoub, Krzysztof Mucha, Mahmoud Kallash, Jeffrey B Kopp, Rasheed Gbadegesin, Brenda W Gillespie, Larry A Greenbaum, Rulan S Parekh, Tracy E Hunley, C John Sperati, David T Selewski, Jason Kidd, Aftab Chishti, Kimberly Reidy, Amy K Mottl, Debbie S Gipson, Tarak Srivastava, Katherine E Twombley, CureGN Consortium, and Katherine Tuttle

Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC). , Soo-Jin Cho, Sarangarajan Ranganathan, Rita Alaggio, Rudolf Maibach, Yukichi Tanaka, Takeshi Inoue, Ivo Leuschner, Ronald de Krijger, Christian Vokuhl, Mark Krailo, Marcio Malogolowkin, Rebecka Meyers, Piotr Czauderna, Eiso Hiyama, Marc Ansari, Bruce Morland, Angela Trobaugh-Lotrario, Allison F O'Neill, Arun Rangaswami, Beate Häberle, and Dolores López-Terrada

Live Broadcast “Examining Complex Heart Failure Case” , Andrew JS Coats, Silvio Inzucchi, Richard Hobbs, and Katherine Tuttle

Improving Metabolic Monitoring during Transfers of Care for Psychiatric Patients Discharged from the Inpatient Psychiatric Residency Service on an Antipsychotic Medication – Part 2 , Allison Cohen and Anisha Boetel

Empagliflozin in Patients with Chronic Kidney Disease. , The EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine R Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, Radica Alicic, Ann Cooper, and Lisa Davis

Tirzepatide decreases systolic and diastolic blood pressure. , Sidar Copur, Atalay Demiray, David Cherney, Katherine Tuttle, and Mehmet Kanbay

Tirzepatide and potential use for metabolically healthy obesity. , Sidar Copur, Cem Tanriover, Furkan Yavuz, Katherine R Tuttle, and Mehmet Kanbay

Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury? , Sidar Copur, Abdullah Yildiz, Carlo Basile, Katherine R Tuttle, and Mehmet Kanbay

The Intake Jailbreak Evaluation of an admission-focused residency team , Alex Crist and Kang X Zhang

Addressing Barriers to Patient Mobilization Using an Educational Intervention in a Hospital Setting , Elena Crooks, Emily Carlson, Tyler Powell, Carly Ruggles, Abel Sawa, Teresa Bigand, Tiffanie Rampley, Rylee Price, Crystal Billings, Danell Stengem, and Jennifer Hoople

Barriers to Early Patient Mobilization Among Acute Care Nurses, Occupational Therapists, and Physical Therapists , Elena Crooks, Carly Ruggles, Emily Carlson, Tyler Powell, Teresa Bigand, Tiffanie Rampley, Crystal Billings, Danell Stengem, Jennifer Hoople, and Rylee Price

Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. , Austin Deets, Parag H Joshi, Alvin Chandra, Kavisha Singh, Amit Khera, Salim S Virani, Christie M Ballantyne, James D Otvos, Robin P F Dullaart, Eke G Gruppen, Margery A Connelly, Colby Ayers, Ann Marie Navar, Ambarish Pandey, John T Wilkins, and Anand Rohatgi

Procedure 63: Continuous Venous Oxygen Saturation Monitoring , Joni L. Dirks

Unit 1: Pulmonary System; Section Two: Special Pulmonary Procedures , Joni L. Dirks

Practices and Outcomes from a Prospective, Multicenter Registry for Preterm Newborns with Pulmonary Hypertension. , Nicolle Fernández Dyess, Claire Palmer, Roger F Soll, Reese H Clark, Steven H Abman, John P Kinsella, Preterm Newborn Pulmonary Hypertension Registry Study Group, and Lisa McGill-Vargas

Needs Assessment: Characterizing resident knowledge gaps in inpatient care of persons with Cystic Fibrosis to inform a quality improvement educational intervention , S Eglin, M Drobny, and AA Lambert

Empagliflozin in Patients with Chronic Kidney Disease. , EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, and The EMPA-KIDNEY Collaborative Group

Efficacy, and safety of remdesivir in people with moderately and severely reduced kidney function hospitalized for COVID-19: The REDPINE study , JRS Fernandez, Katherine Tuttle, and See full list of authors in comments

American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations. , Nauzer Forbes, Sherif E Elhanafi, Mohammad A Al-Haddad, Nirav C Thosani, Peter V Draganov, Mohamed O Othman, Eugene P Ceppa, Vivek Kaul, Michael M Feely, Ilyas Sahin, James L Buxbaum, Audrey H Calderwood, Jean M Chalhoub, Nayantara Coelho-Prabhu, Madhav Desai, Larissa L Fujii-Lau, Divyanshoo R Kohli, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly Ruan, Sunil G Sheth, Andrew C Storm, Nikhil R Thiruvengadam, and Bashar J Qumseya

Minds for Hearts - A Targeted Education Project Focused on Cardiovascular Health in the Psychiatric Community , Peter Franz and Anisha Boetel

ASGE Guideline on the role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: Summary and Recommendations. , Larissa L Fujii-Lau, Nirav C Thosani, Mohammad Al-Haddad, Jared Acoba, Curtis J Wray, Rodrick Zvavanjanja, Stuart K Amateau, James L Buxbaum, Audrey H Calderwood, Jean M Chalhoub, Nayantara Coelho-Prabhu, Madhav Desai, Sherif E Elhanafi, Douglas S Fishman, Nauzer Forbes, Laith H Jamil, Terry L Jue, Divyanshoo R Kohli, Richard S Kwon, Joanna K Law, Jeffrey K Lee, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly Ruan, Mandeep S Sawhney, Sunil G Sheth, Andrew Storm, Nikhil R Thiruvengadam, Bashar J Qumseya, and ASGE Standards of Practice Committee Chair (2020-2023)

ASGE Guideline on role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: Methodology and Review of Evidence. , Larissa L Fujii-Lau, Nirav C Thosani, Mohammad Al-Haddad, Jared Acoba, Curtis J Wray, Rodrick Zvavanjanja, Stuart K Amateau, James L Buxbaum, Sachin Wani, Audrey H Calderwood, Jean M Chalhoub, Nayantara Coelho-Prabhu, Madhav Desai, Sherif E Elhanafi, Douglas S Fishman, Nauzer Forbes, Laith H Jamil, Terry L Jue, Divyanshoo R Kohli, Richard S Kwon, Joanna K Law, Jeffrey K Lee, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly Ruan, Mandeep S Sawhney, Sunil G Sheth, Andrew Storm, Nikhil R Thiruvengadam, Bashar J Qumseya, and ASGE Standards of Practice Committee Chair (2020-2023)

Relationships Between Perceived Importance of Chaplain Presence and Health Professionals' Emotional Well-Being in the United States. , Adam Gaines, Teresa Rangel, Rachel Freedberg, Sheila Doucette, Danell Stengem, Rosemary Timmerman, Jamie Roney, Patrick Arenivar, Angela Patterson, JoAnn Long, Sarah Sumner, Dawn Bock, Sherri Mendelson, Trisha Saul, AnneMarie West, Robert E Leavitt, and Karen Colorafi

Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD. , Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle

National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017. , Rodolfo J Galindo, Shealeigh A Inselman, Guillermo E Umpierrez, Bobak Moazzami, Jair Munoz Mendoza, Mohammed K Ali, Katherine R Tuttle, and Rozalina G McCoy

960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM) , Rodolfo J. Galindo, Bobak Mozzami, Amany Y.G. Gerges, Limin Peng, Katherine R. Tuttle, and Guillermo Umpierrez

961-P: Comparison of Glucose Metrics by Capillary Blood Glucose and Continuous Glucose Monitoring among People with Type 2 Diabetes on Hemodialysis , Rodolfo J. Galindo, Bobak Mozzami, Amany Y.G. Gerges, Limin Peng, Katherine R. Tuttle, and Guillermo Umpierrez

960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM) , Rodolfo J. Galindo, Katherine Tuttle, and See full list of authors in comments

Feasibility of intraoperative injection of radioactive tracer and blue dye for sentinel lymph node biopsy in vulvar cancer. , Alison A Garrett, Jason Ricciuti, Susan M Lang, Mary E Burriss, Margaret Flanigan, Emily O'Brien, Casey Hay, Jamie Lesnock, Jessica L Berger, and Sarah E Taylor

Benzodiazepine-minimizing protocol for alcohol withdrawal: a comparative analysis , Jennifer Gaston, Hsin-Fang Li, Emily J Cox, Caitlin Klamper, and John F Wurzel

Improving Caregiver Confidence and Burnout through Standardizing the use of the Agitated Behavior Scale and Behavioral Strategies for Managing Patients with Agitation , John Gilmer, Kate Whiteneck, Alicia Hegie, Mackenzie Waples, and Frank Jackson

A HAPI Reduction QI Project: Don't Leave Your Patient in S.H.A.M.B.L.E.S , Anissa Guzman, Ashlee Garcia, and Valerie Lindsay

Treating Opioid Use Disorder: One Shot at a Time , Shelly Haferkamp, Michael P. Kinney, Daniel Yang, Lindsey Cunningham, Anna Davey, and Amy G Burns

Supporting Designated Crisis Responders (DCRs) in Washington State , Shelly Haferkamp, James Miller, and John F Wurzel

Embracing Scrutiny: The Importance of Critical Evaluation and Transparency in Research. , Ross S Hanson, Ollin G Venegas, Lindsey A Alverson, Benjamin A Abrams, and Miklos D Kertai

Code Status in the Inpatient Setting , Alyssa Harper, Travis Fisher, Marjorie Schoen, Caroline Pappas, and Ian May

Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial. , Hiddo J L Heerspink, Andreas L Birkenfeld, David Z I Cherney, Helen M Colhoun, Linong Ji, Chantal Mathieu, Per-Henrik Groop, Richard E Pratley, Sylvia E Rosas, Peter Rossing, Jay S Skyler, Katherine R Tuttle, Robert Lawatscheck, Charlie Scott, Robert Edfors, Markus F Scheerer, Peter Kolkhof, and Janet B McGill

People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action. , Hiddo Jl Heerspink, David Zi Cherney, Per-Henrik Groop, Chantal Matthieu, Peter Rossing, Katherine R Tuttle, and Janet B McGill

Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis. , Hiddo J L Heerspink, Naveed Sattar, Imre Pavo, Axel Haupt, Kevin L Duffin, Zhengyu Yang, Russell J Wiese, Jonathan M Wilson, Andrea Hemmingway, David Z I Cherney, and Katherine Tuttle

Tirzepatide reduces albuminuria in patients with type 2 diabetes: post-hoc pooled analysis of SURPASS 1-5 , Hiddo J. Heerspink, Katherine Tuttle, and See full list of authors in comments

Design, and baseline characteristics of the FIND-CKD trial: Efficacy of Finerenone on kidney disease progression in people with non[1]diabetic chronic kidney disease , HJL Heerspink, Katherine Tuttle, and See all authors in comments

Implementing Team Birth to Improve Patient Satisfaction on an LDRP (Team BirthSingleRoom ) Unit , Deanna Higgins, Alyson WIllard, and Teresa Rangel

Standardized Follow-Up Recommendations Improve Reporting of Incidental Renal Lesions in a Community Setting. , Michael G Johnston, Skyler Burke, Chance M Brock, Saralyn Beckius, and Scott King

Management of pediatric toxic ingestions in the emergency department. , Mia Kanak, Stacy M Tarango, and Deborah R Liu

The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta-analysis. , Mehmet Kanbay, Sidar Copur, Dimitrie Siriopol, Abdullah B Yildiz, Metehan Berkkan, Kathherine R Tuttle, and Carmine Zoccali

• Collections
• Disciplines
• Providence Research
• Providence Washington

Advanced Search

• Notify me via email or RSS

PSJH Research

• Research & Clinical Trials

Home | About | FAQ | My Account | Accessibility Statement

Privacy Copyright

Quick Links

• UW HR Resources

Katherine R. Tuttle MD, FASN, FACP, FNKF

[email protected]

Providence Medical Research Center 104 W. 5th Avenue Suite 350E Spokane, WA 99204

National and International Responsibilities:

ASN Continuous Professional Development Committee Member 2024-2025

Cardiometabolic Health Congress (CMHC) Women’s Health and Wellness Masterclass: “Women and Chronic Kidney Disease” 2023

University of Alaska, Board Member, Transformative Research in Metabolism (TRiM) President Professors Program 2020-present

Weill Cornell Medicine|NewYork Presbyterian, Member, Technical Expert Panel (TEP) for Diabetic Kidney Disease 2020

Scientific Success Committee, Institute of Translational Health Sciences, University of Washington, Member 2019-present

Regional Executive Committee, Institute of Translational Health Sciences, University of Washington, Chair 2019-present

Co-Chair, National Kidney Foundation Workshop SGLT2 Inhibitors in DKD 2019

EMPA-KIDNEY Study, Oxford University, Clinical Trials Service Unit, Member, Steering Committee 2018-present

Kidney Disease Improving Global Outcomes (KDIGO), Member, KDIGO Management of Diabetes & CKD Guideline Work Group 2018-present

Diabetic Kidney Disease Task Force Member, ASN 2018

Member, 79th ADA Scientific Sessions Program Committee for Nephropathy 2018

University of Washington Institute of Translational Health Sciences Regional Collaborations Program, Member, Selection Committee for the KL2 Program 2018

University of Washington School of Medicine / Gonzaga University, Member, Regional Health Partnership Research Task Force 2017-present

Member, ADA Scientific Sessions Nephropathy Subcommittee 2017

Kidney Health Initiative, Chair, Program Committee for 5th Annual Kidney Health Initiative Stakeholders Meeting 2016-2017

Northwest Participant and Clinical Interactions Research Center Network, Institute of Translational Health Sciences, University of Washington, Network Director 2016-present

Canadian Institutes of Health Research’s Strategy on Patient-Oriented Research (SPO), Member, Can-SOLVE CKD International Research Advisory Committee (CIRAC) 2016

ISN World Congress of Nephrology Scientific Program Committee, Co-Chair 2015-2017

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Member, CureGN, Publications, and Presentations Committee 2015-present

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Chair, ICD-PIECES, Data Safety Monitoring Board 2015-present

University of Washington Institute of Translational Health Sciences Regional Collaborations Program, Co-Principal Investigator 2015-present

University of Washington Institute of Translational Health Sciences Regional Collaborations Program, Chair, Regional Advisory Workgroup 2015-present

University of Washington Institute of Translational Health Sciences Regional Collaborations Program, Director, Northwest Participant, and Clinical Interactions Network 2015-present

Providence Health & Services, Member, Research Leadership Council 2015-present

Providence Health & Services, Member, Executive Committee 2015-present

Co-Chair 2017 World Congress of Nephrology Scientific Program Committee 2015-2017

National Kidney Foundation, Member, Steering Committee for the TACKLE Study 2015

American Society of Nephrology Kidney Week, 2015 Member, Program Committee 2015

Kidney Health Initiative, Member, Board of Directors, ASN representative 2014-2019

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Diabetes Education Program, Member, STOP-DKD, Data Safety Monitoring Board 2014-present

National Kidney Foundation,  Member, Research Program Task Force 2014

Member, ASN-XPrize Visioneering Workgroup 2014

Co-Chair, Consensus Conference on Chronic Kidney Disease and Diabetes 2014

Member, ASN Nominating Committee 2013-14

Veterans Administration, Department of Defense Chairperson 2013

Peer-Reviewed Medical Research Program 2013

Chair, Translating Chronic Kidney Disease (CKD) Research into Improved Clinical Outcomes - The Science of Type 2 Translation (T2) Committee, National Institute for Diabetes, Digestive, and Kidney Diseases (NIDDK) 2010-present

Associate Editor, Clinical Journal for the American Society of Nephrology (CJASN) 2010-present

Member, Post-Graduate Education Committee, American Society of Nephrology 2010-present

Member, Narins Award Committee and Peters Award Committee, ASN 2010-2012

Member, Scribner Award Committee, ASN 2009-2012

Member, Data Safety Monitoring Board, Veterans Affairs Cooperative Study Group NEPHRON-D Trial 2009-2013

Chair, Health Care Provider Work Group, National Diabetes Education Program, National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Disease, 2007-present (Member 2004-present)

Member, Planning Committee, Proteinuria as a Surrogate Outcome in Chronic Kidney Disease, National Kidney Foundation and United States Food and Drug Administration Consensus Panel 2007-present

Member, Operations and Steering Committees for the CORAL Trial, National Institutes of Health, National Heart, Lung and Blood Institute, 2006-present

Chair, Risk Factor Committee, Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) Trial, 2006-present

Co-Chair, Diabetes and Chronic Kidney Disease Workgroup, National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (KDOQI) 2003-present

Spokane Society of Internal Medicine, President 2003

Spokane Society of Internal Medicine, Chair, Program Committee 2003

Spokane Society of Internal Medicine, Chair, Update in Internal Medicine 2003

Institutional Review Board-Spokane; Spokane, Washington 1999-2012

Spokane Society of Internal Medicine, Member, Program Committee 1999-2002

Member, Consensus Panel on Treatment of High Blood Pressure in Diabetes, National Kidney Foundation 1999

Member, Executive Council on Hypertension, National Kidney Foundation 1998-present

Institutional Review Board-Spokane; Spokane, Washington, Member 1995-2012

Alpha Omega Alpha 1986

Outstanding Clinical Faculty, Internal Medicine-Spokane 1992

Woman of Distinction: Girl Scouts Inland Empire Council 2000

Fellowship: American College of Physicians-American Society of Internal Medicine 2001

Fellow of the American Society of Nephrology 2004

YWCA Woman of Achievement Award in Science 2009

Alpha Omega Alpha Clinical Faculty Award, University of Washington School of Medicine 2012

Florence Ettleson Memorial Lecture at Providence St. Vincent Medical Center and Providence Portland Medical Center 2013

Allen I. White Distinguished Lectureship Lecture at Washington State University College of Pharmacy 2014

Robert & Elaine Collins Lectureship at University of Colorado School of Medicine 2015

Spokane Citizen Hall of Fame Honoree for Health, Medicine, and Science 2015

Fellow of the National Kidney Foundation 2016

National Kidney Foundation (NKF) - Garabed Eknoyan Award For exceptional contributions to clinical research and key initiatives of National Kidney Foundation 2017

John T. Harrington, MD Endowed Professor, and Lectureship, World Kidney Day, Tufts University School of Medicine 2018

Spokane Citizen Hall of Fame Inductee for Science, Health, and Medicine 2018

Gerald Schulman Endowed Professor and Lectureship, Vanderbilt University Medical Center 2019

American Association of Kidney Patients (AAKP) Medal of Excellence Award 2020

Annual Lancet Lecturer 2023

American Society of Nephrology Lifetime Achievement, John P. Peters Award 2023

American Journal of Kidney Disease, 2023 Editor’s Choice Award “Racial and Ethnic Disparities in Acute Care Utilization Among Patients with Glomerular Disease”

Education & Training

Nephrology Fellowship  University of Texas Health Sciences Center San Antonio, TX 1988

Endocrinology and Metabolism Fellowship Washington University St. Louis, MO 1986

Medicine Residency Northwestern University Medical School Chicago, IL 1985

Medical School Northwestern University Medical School Chicago, IL 1982

Clinical Interests

• Diabetic kidney disease
• Hypertension
• Renal vascular disease
• Chronic kidney diseases

Research Interests

• Clinical and translational science for diabetes and chronic kidney disease
• Diabetic kidney disease: cellular and molecular mechanisms, clinical research in novel therapeutic agents
• Nutrition: Cellular and molecular mechanisms of dietary protein-induced kidney damage, clinical research on optimal dietary interventions
• Hypertension: clinical research in defining selection of therapeutic combinations
• Renal vascular disease: A randomized clinical trial of medical versus interventional strategy

Publications

• Today's news
• Reviews and deals
• Climate change
• 2024 election
• Fall allergies
• Health news
• Mental health
• Sexual health
• Family health
• So mini ways
• Unapologetically
• Buying guides

Entertainment

• How to Watch
• My Portfolio
• Latest News
• Stock Market
• Premium News
• Biden Economy
• EV Deep Dive
• Stocks: Most Actives
• Stocks: Gainers
• Stocks: Losers
• Trending Tickers
• World Indices
• US Treasury Bonds
• Top Mutual Funds
• Highest Open Interest
• Highest Implied Volatility
• Stock Comparison
• Advanced Charts
• Currency Converter
• Basic Materials
• Communication Services
• Consumer Cyclical
• Consumer Defensive
• Financial Services
• Industrials
• Real Estate
• Mutual Funds
• Credit cards
• Balance Transfer Cards
• Cash-back Cards
• Rewards Cards
• Travel Cards
• Personal Loans
• Student Loans
• Car Insurance
• Morning Brief
• Market Domination
• Market Domination Overtime
• Opening Bid
• Stocks in Translation
• Lead This Way
• Good Buy or Goodbye?
• Fantasy football
• Pro Pick 'Em
• College Pick 'Em
• Fantasy baseball
• Fantasy hockey
• Fantasy basketball
• Download the app
• Daily fantasy
• Scores and schedules
• GameChannel
• World Baseball Classic
• Premier League
• CONCACAF League
• Champions League
• Motorsports
• Horse racing
• Newsletters

New on Yahoo

• Privacy Dashboard

Yahoo Finance

Providence to invest $177 million to address portland's most urgent health care challenges.

More than 80% of funding through historic Tomorrow Starts Today capital campaign

PORTLAND, Ore. , May 14, 2024 /PRNewswire/ -- Today, Providence announced investments totaling $177 million to address Portland's most urgent health care challenges by re-imagining emergency and critical cardiac care at Providence Portland and Providence St. Vincent Medical Centers, including Providence Heart Institute.

Together, these improvements will provide room for an additional 50,000 emergency department visits each year – the equivalent of an entirely new emergency department for Portland – and support Providence Heart Institute as it cares for a growing number of patients with much more complex cardiac conditions than patients in the past.

This commitment is the result of Tomorrow Starts Today , a capital campaign to enable faster, better care for more people. More than 80% of the total funding – $144 million – for today's announcement will come from generous donors, making it the largest campaign in Providence Oregon's history.

"Philanthropy has enabled Providence to care for Oregonians and patients in the Pacific Northwest for almost 170 years," said Laurie Kelley , Providence chief philanthropy officer. "Today's health care challenges require urgent fixes that quite simply will not be possible without the generous support of our current and future donors."

With health care facilities nationwide struggling with overcrowding and dated infrastructure, Portland's providers face similarly pressing circumstances. Annually, patients make more than 200,000 emergency room visits to Providence's Portland area hospitals, including an increasing number of individuals with mental health needs.

Tomorrow Starts Today will create more capacity and innovation across Portland through investments of $92 million in expanded and re-imagined emergency departments at Providence St. Vincent and Providence Portland and $85 million to expand critical cardiac care facilities, including a new cardiac intensive care unit, at Providence St. Vincent.

"Our emergency departments in Portland are staring down challenges that grow more significant by the day," said Ray Moreno , M.D., Providence St. Vincent chief medical officer. "Far too often we are caring for people in hallways and turning away ambulances due to overcrowding. Our patients, our caregivers, and our communities deserve better."

Similar pressures are mounting for Providence Heart Institute, whose facilities were not built to handle patients who may spend weeks or even months in the cardiac intensive care unit (CICU). " Providence has proudly grown into one of the largest providers of complex cardiac care on the West Coast and a national center of excellence, but the patients we're seeing today have much more complex cardiac care needs," said Dan Oseran, M.D., Providence Heart Institute executive medical director. "This is our opportunity to re-imagine cardiac care for the next 50 years and ensure that Portland remains a world-class destination for heart care."

Tomorrow Starts Today will deliver transformative changes for Providence patients, including:

Reduced or eliminated wait times in the emergency department.

Critical innovations and new facilities so Providence Heart Institute can provide the very best in complex cardiac care to more people as a national center of excellence.

Improved safety, security, and comfort for patients and caregivers.

More lives saved and better outcomes in areas of urgent need, including behavioral health, pediatrics, and stroke care.

New flexible sites of care to accommodate more patients in moments of crisis such as a pandemic or natural disaster, and dedicated treatment rooms for people experiencing substance use crises and related behavioral health issues.

The large and complex expansion and renovation projects began in 2023 and are expected to be completed by 2027. Today's announcement is the first time the entirety of Providence's capital improvement plans has been shared with the public. Projects are being strategically staggered in phases to maintain care capacity during construction.

Andy and Nancy Bryant are co-chairing the effort to raise funds for the Providence St. Vincent emergency department, inspired by Andy and other family members' care in that facility.

"The critical care we received from Providence is the best we have received anywhere in the country," said the Bryants. "Now we want to give the same gift to others. We strongly believe that there is no more impactful investment you can make for Portland's future than donating to Tomorrow Starts Today. We invite others to join us and help Providence reimagine care for our city to ensure excellent care is available and accessible to all those who need it."

The Bryants are joined in their early support of this transformative campaign by other lead donors including Tim and Mary Boyle , the Lematta Family, Pat Reser and Bill Westphal , Mark and Mary Stevens , JTMF Foundation, The Chiles Foundation, The Zidell Family Foundation and others who have helped raise more than $125 million toward the campaign goal of $144 million in philanthropic funding.

"The fact that our community is rallying around this campaign is truly inspiring to all of us who work on the front lines providing care. We are so grateful," said Jeremy Lynn, M.D., Providence regional director of emergency services and Providence Portland emergency department physician. "We got into this work so we could help people on their worst day. We are excited to do that in updated and expanded spaces that will allow us to provide better, faster care for more people."

To learn more about the capital improvements and join the campaign, visit  providencefoundations.org/tomorrow .

About Providence Foundations of Oregon  Providence is a national, not-for-profit Catholic health system compromising a diverse family of organizations and driven by a belief that health is a human right. The financial support of Providence donors is critical to continuing groundbreaking research, bringing the latest technology and equipment to our facilities, and improving the health of our communities through programs that simply would not exist without philanthropy. Learn more at www.ProvidenceFoundations.org

View original content to download multimedia: https://www.prnewswire.com/news-releases/providence-to-invest-177-million-to-address-portlands-most-urgent-health-care-challenges-302144244.html

SOURCE Providence Foundations of Oregon

Oregon AG seeks Providence Health documents in charity care investigation

O regon Attorney General Ellen Rosenblum has asked a judge to force Providence Health & Services to turn over documents in an investigation of the health system’s charity care program .

Filings from the state Department of Justice allege Providence enacted policies meant to minimize free medical care to low-income patients, sending some to collections when they couldn’t pay. The department said it’s investigating the practice as a “potential” violation of the state’s Unlawful Trade Practices Act, a consumer protection law, as well as charity care laws that require the nonprofit health system to provide free care to low-income patients in exchange for its various tax exemptions. It has not yet filed a complaint in the case, which it’s pursuing as a civil matter, not a criminal one.

The Justice Department attorneys say Providence has declined to search through and turn over some documents sought by investigators from 10 managers, each of them involved in billing or patients’ access to health care services. Investigators sought documents that match certain search parameters, including key words like “bad debt” and “charity” that appear near each other.

Providence said it has cooperated fully in the investigation by producing 100,000 documents, responding to questions and making 10 witnesses available for lengthy interviews. The health system, though, argued the Justice Department’s later document requests were “overly broad.”

It said it estimated the department’s requests cover another 200,000 documents, which it said would take its attorneys 3,500 hours to review at a cost of about $675,000. Providence said it has already spent $2.4 million responding to the DOJ investigation. In a statement, Providence said it simply asked the Justice Department to narrow its requests for records.

“We intend to defend our position in court and look forward to reaching a resolution that is satisfactory to all parties,” Providence said in the statement.

Providence earlier this year settled a lawsuit brought by Washington state’s attorney general over charity-care claims. The health system, which has its headquarters in Renton, Washington, agreed to refund $21 million paid by low-income patients in Washington who were eligible for charity care and erase $137 million in outstanding debt.

Central to both cases is a Providence initiative to increase its cash collections that began in 2018.

In its filings, the Oregon Justice Department disclosed documents obtained from Providence that it says suggest the program was designed to squeeze patients for payments, then send them to collections if they couldn’t pay.

An email and training materials, for example, outlined policies that encouraged employees to seek up-front payments — even partial payments — during meetings with patients in their hospital rooms and to bring up the possibility of financial assistance only as a “last resort.”

It called the program “RevUp.” Providence has said the program was short-lived and primarily aimed at commercially insured patients with the ability to pay, but it also has acknowledged the program was “not consistent” with its values .

Other documents, the Justice Department said, suggest Providence sent patients enrolled in Medicaid to collections in violation of state law.

Providence had systems to identify patients eligible for charity care, according to Justice Department filings. But state attorneys say the health system delayed notifying those patients of their eligibility and took payments from them regardless, then made them apply for refunds, in some cases under a 30-day deadline.

Oregon’s Justice Department began its probe in 2022, acknowledging its consumer protection unit was pursuing a civil investigation but saying little more at the time about the subject matter. It followed the Washington state investigation, as well as a New York Times investigation of the RevUp program that included examples of Oregonians who qualified for charity care but were charged anyway, then hounded by collections agencies.

Providence operates in six western states. It has eight hospitals in Oregon and more than 200 clinics and other offices.

— Elliot Njus edits business news. Contact him at [email protected] .

— Jeff Manning covers business news. Reach him at [email protected] .

Our journalism needs your support. Subscribe today .

©2024 Advance Local Media LLC. Visit oregonlive.com. Distributed by Tribune Content Agency, LLC.

Raimondo, state leaders celebrate work on new NOAA center in Newport. Why it's coming to RI

NEWPORT – Commerce Secretary Gina Raimondo was back in her home state Monday to celebrate the groundbreaking for the new headquarters of the National Oceanic and Atmospheric Administration’s Atlantic Ocean research fleet . 

Raimondo, former governor of Rhode Island, joined her successor, Dan McKee, and the state’s congressional delegation Monday morning at Naval Station Newport, where workers are already building the $147-million operations center that will support climate research, fisheries surveys, nautical charting and other work to better understand the ocean environment. 

The bulk of the funding for the project is coming from the 2022 Inflation Reduction Act , which was largely aimed at addressing the impacts of climate change. 

“Here in the Ocean State, climate change is real,” Raimondo said. “We know the risks – but also the opportunities – that come with living and working along the coast.”  

NOAA is moving center to Newport from Virginia

She spoke as construction crews in the background drove piles for the pier that will become the homeport for four NOAA research ships. The facility, which is expected to be completed in 2027, will also include a floating dock for smaller vessels, repair space and a building for shoreside support and storage. About 150 NOAA personnel will be based at the center. 

NOAA, which is part of the Department of Commerce, is moving its Atlantic operations center from Norfolk, Virginia, to Newport. It will be one of two main operations centers for NOAA’s fleet of 15 research and survey vessels. The other one, serving the Pacific Ocean, is in Newport, Oregon. 

Rear Admiral Nancy Hann, director of NOAA’s marine and aviation operations, said the Newport site was chosen in part for its proximity to facilities operated by the U.S. Navy and the Coast Guard, which work closely with her agency. 

She said that future projections of sea level rise and other climate impacts also factored into the decision. 

“We need a climate-resilient facility,” Hann said. “We need to know that if we’re making this investment, we can use it for decades to come.”  

NOAA has been expanding its presence in Rhode Island in recent years

NOAA has gradually been expanding its presence in the City by the Sea during the past decade. In 2016, Newport became homeport for the Henry B. Bigelow, a 209-foot-long fisheries research ship. It was later joined by the Okeanos Explorer, a 224-foot-long ship that specializes in exploration of the deep ocean. 

The Thomas Jefferson, a 208-foot-long survey ship, is set to also come to Newport, as is the Discoverer, a 244-foot-long research vessel under construction in Louisiana. 

Raimondo and others at the ceremony credited U.S. Sen. Jack Reed for working to secure NOAA’s commitment to Newport. 

Reed said that locating the NOAA center in Newport makes sense because it’s also close to academic institutions, including Woods Hole Oceanographic Institute and the Graduate School of Oceanography at the University of Rhode Island. 

“We’re at the intersection of all of the blue economy and blue research – I think not just on the East Coast but everywhere,” Reed said. 

Green building designs to be used for new facility

Hann said that NOAA is employing climate-friendly practices at the new facility. The operations building was designed to minimize its carbon footprint and will be certified by LEED, Leadership in Energy and Environmental Design, which oversees the most common rating system in the United States for green construction. It will include energy-efficient mechanical systems and will maximize the use of natural light, she said. 

In addition, the Discoverer will have lower emissions than comparable vessels by employing a hybrid propulsion system that combines diesel engines with battery storage, she said. 

NOAA’s research is used in everything from weather forecasting to fisheries management. Hann said that it’s also important to national security.  

She pointed to the agency’s work after a container ship struck the Francis Scott Key Bridge in Baltimore in March and caused it to collapse. She said that NOAA mapped an alternative shipping channel under the bridge so the Port of Baltimore could reopen. 

None of NOAA’s vessels were in port for Monday’s ceremony. 

“You’ll have to imagine our ships here, because they’re all out working,” Hann said. 

40 Facts About Elektrostal

Written by Lanette Mayes

Modified & Updated: 10 May 2024

Reviewed by Jessica Corbett

Elektrostal is a vibrant city located in the Moscow Oblast region of Russia. With a rich history, stunning architecture, and a thriving community, Elektrostal is a city that has much to offer. Whether you are a history buff, nature enthusiast, or simply curious about different cultures, Elektrostal is sure to captivate you.

This article will provide you with 40 fascinating facts about Elektrostal, giving you a better understanding of why this city is worth exploring. From its origins as an industrial hub to its modern-day charm, we will delve into the various aspects that make Elektrostal a unique and must-visit destination.

So, join us as we uncover the hidden treasures of Elektrostal and discover what makes this city a true gem in the heart of Russia.

Key Takeaways:

• Elektrostal, known as the “Motor City of Russia,” is a vibrant and growing city with a rich industrial history, offering diverse cultural experiences and a strong commitment to environmental sustainability.
• With its convenient location near Moscow, Elektrostal provides a picturesque landscape, vibrant nightlife, and a range of recreational activities, making it an ideal destination for residents and visitors alike.

Known as the “Motor City of Russia.”

Elektrostal, a city located in the Moscow Oblast region of Russia, earned the nickname “Motor City” due to its significant involvement in the automotive industry.

Home to the Elektrostal Metallurgical Plant.

Elektrostal is renowned for its metallurgical plant, which has been producing high-quality steel and alloys since its establishment in 1916.

Boasts a rich industrial heritage.

Elektrostal has a long history of industrial development, contributing to the growth and progress of the region.

Founded in 1916.

The city of Elektrostal was founded in 1916 as a result of the construction of the Elektrostal Metallurgical Plant.

Located approximately 50 kilometers east of Moscow.

Elektrostal is situated in close proximity to the Russian capital, making it easily accessible for both residents and visitors.

Known for its vibrant cultural scene.

Elektrostal is home to several cultural institutions, including museums, theaters, and art galleries that showcase the city’s rich artistic heritage.

A popular destination for nature lovers.

Surrounded by picturesque landscapes and forests, Elektrostal offers ample opportunities for outdoor activities such as hiking, camping, and birdwatching.

Hosts the annual Elektrostal City Day celebrations.

Every year, Elektrostal organizes festive events and activities to celebrate its founding, bringing together residents and visitors in a spirit of unity and joy.

Has a population of approximately 160,000 people.

Elektrostal is home to a diverse and vibrant community of around 160,000 residents, contributing to its dynamic atmosphere.

Boasts excellent education facilities.

The city is known for its well-established educational institutions, providing quality education to students of all ages.

A center for scientific research and innovation.

Elektrostal serves as an important hub for scientific research, particularly in the fields of metallurgy, materials science, and engineering.

Surrounded by picturesque lakes.

The city is blessed with numerous beautiful lakes, offering scenic views and recreational opportunities for locals and visitors alike.

Well-connected transportation system.

Elektrostal benefits from an efficient transportation network, including highways, railways, and public transportation options, ensuring convenient travel within and beyond the city.

Famous for its traditional Russian cuisine.

Food enthusiasts can indulge in authentic Russian dishes at numerous restaurants and cafes scattered throughout Elektrostal.

Home to notable architectural landmarks.

Elektrostal boasts impressive architecture, including the Church of the Transfiguration of the Lord and the Elektrostal Palace of Culture.

Offers a wide range of recreational facilities.

Residents and visitors can enjoy various recreational activities, such as sports complexes, swimming pools, and fitness centers, enhancing the overall quality of life.

Provides a high standard of healthcare.

Elektrostal is equipped with modern medical facilities, ensuring residents have access to quality healthcare services.

Home to the Elektrostal History Museum.

The Elektrostal History Museum showcases the city’s fascinating past through exhibitions and displays.

A hub for sports enthusiasts.

Elektrostal is passionate about sports, with numerous stadiums, arenas, and sports clubs offering opportunities for athletes and spectators.

Celebrates diverse cultural festivals.

Throughout the year, Elektrostal hosts a variety of cultural festivals, celebrating different ethnicities, traditions, and art forms.

Electric power played a significant role in its early development.

Elektrostal owes its name and initial growth to the establishment of electric power stations and the utilization of electricity in the industrial sector.

Boasts a thriving economy.

The city’s strong industrial base, coupled with its strategic location near Moscow, has contributed to Elektrostal’s prosperous economic status.

Houses the Elektrostal Drama Theater.

The Elektrostal Drama Theater is a cultural centerpiece, attracting theater enthusiasts from far and wide.

Popular destination for winter sports.

Elektrostal’s proximity to ski resorts and winter sport facilities makes it a favorite destination for skiing, snowboarding, and other winter activities.

Promotes environmental sustainability.

Elektrostal prioritizes environmental protection and sustainability, implementing initiatives to reduce pollution and preserve natural resources.

Home to renowned educational institutions.

Elektrostal is known for its prestigious schools and universities, offering a wide range of academic programs to students.

Committed to cultural preservation.

The city values its cultural heritage and takes active steps to preserve and promote traditional customs, crafts, and arts.

Hosts an annual International Film Festival.

The Elektrostal International Film Festival attracts filmmakers and cinema enthusiasts from around the world, showcasing a diverse range of films.

Encourages entrepreneurship and innovation.

Elektrostal supports aspiring entrepreneurs and fosters a culture of innovation, providing opportunities for startups and business development.

Offers a range of housing options.

Elektrostal provides diverse housing options, including apartments, houses, and residential complexes, catering to different lifestyles and budgets.

Home to notable sports teams.

Elektrostal is proud of its sports legacy, with several successful sports teams competing at regional and national levels.

Boasts a vibrant nightlife scene.

Residents and visitors can enjoy a lively nightlife in Elektrostal, with numerous bars, clubs, and entertainment venues.

Promotes cultural exchange and international relations.

Elektrostal actively engages in international partnerships, cultural exchanges, and diplomatic collaborations to foster global connections.

Surrounded by beautiful nature reserves.

Nearby nature reserves, such as the Barybino Forest and Luchinskoye Lake, offer opportunities for nature enthusiasts to explore and appreciate the region’s biodiversity.

Commemorates historical events.

The city pays tribute to significant historical events through memorials, monuments, and exhibitions, ensuring the preservation of collective memory.

Promotes sports and youth development.

Elektrostal invests in sports infrastructure and programs to encourage youth participation, health, and physical fitness.

Hosts annual cultural and artistic festivals.

Throughout the year, Elektrostal celebrates its cultural diversity through festivals dedicated to music, dance, art, and theater.

Provides a picturesque landscape for photography enthusiasts.

The city’s scenic beauty, architectural landmarks, and natural surroundings make it a paradise for photographers.

Connects to Moscow via a direct train line.

The convenient train connection between Elektrostal and Moscow makes commuting between the two cities effortless.

A city with a bright future.

Elektrostal continues to grow and develop, aiming to become a model city in terms of infrastructure, sustainability, and quality of life for its residents.

In conclusion, Elektrostal is a fascinating city with a rich history and a vibrant present. From its origins as a center of steel production to its modern-day status as a hub for education and industry, Elektrostal has plenty to offer both residents and visitors. With its beautiful parks, cultural attractions, and proximity to Moscow, there is no shortage of things to see and do in this dynamic city. Whether you’re interested in exploring its historical landmarks, enjoying outdoor activities, or immersing yourself in the local culture, Elektrostal has something for everyone. So, next time you find yourself in the Moscow region, don’t miss the opportunity to discover the hidden gems of Elektrostal.

Q: What is the population of Elektrostal?

A: As of the latest data, the population of Elektrostal is approximately XXXX.

Q: How far is Elektrostal from Moscow?

A: Elektrostal is located approximately XX kilometers away from Moscow.

Q: Are there any famous landmarks in Elektrostal?

A: Yes, Elektrostal is home to several notable landmarks, including XXXX and XXXX.

Q: What industries are prominent in Elektrostal?

A: Elektrostal is known for its steel production industry and is also a center for engineering and manufacturing.

Q: Are there any universities or educational institutions in Elektrostal?

A: Yes, Elektrostal is home to XXXX University and several other educational institutions.

Q: What are some popular outdoor activities in Elektrostal?

A: Elektrostal offers several outdoor activities, such as hiking, cycling, and picnicking in its beautiful parks.

Q: Is Elektrostal well-connected in terms of transportation?

A: Yes, Elektrostal has good transportation links, including trains and buses, making it easily accessible from nearby cities.

Q: Are there any annual events or festivals in Elektrostal?

A: Yes, Elektrostal hosts various events and festivals throughout the year, including XXXX and XXXX.

Elektrostal's fascinating history, vibrant culture, and promising future make it a city worth exploring. For more captivating facts about cities around the world, discover the unique characteristics that define each city . Uncover the hidden gems of Moscow Oblast through our in-depth look at Kolomna. Lastly, dive into the rich industrial heritage of Teesside, a thriving industrial center with its own story to tell.

Was this page helpful?

Our commitment to delivering trustworthy and engaging content is at the heart of what we do. Each fact on our site is contributed by real users like you, bringing a wealth of diverse insights and information. To ensure the highest standards of accuracy and reliability, our dedicated editors meticulously review each submission. This process guarantees that the facts we share are not only fascinating but also credible. Trust in our commitment to quality and authenticity as you explore and learn with us.

Share this Fact:

Current time by city

For example, New York

Current time by country

For example, Japan

Time difference

For example, London

For example, Dubai

Coordinates

For example, Hong Kong

For example, Delhi

For example, Sydney

Geographic coordinates of Elektrostal, Moscow Oblast, Russia

City coordinates

Coordinates of Elektrostal in decimal degrees

Coordinates of elektrostal in degrees and decimal minutes, utm coordinates of elektrostal, geographic coordinate systems.

WGS 84 coordinate reference system is the latest revision of the World Geodetic System, which is used in mapping and navigation, including GPS satellite navigation system (the Global Positioning System).

Geographic coordinates (latitude and longitude) define a position on the Earth’s surface. Coordinates are angular units. The canonical form of latitude and longitude representation uses degrees (°), minutes (′), and seconds (″). GPS systems widely use coordinates in degrees and decimal minutes, or in decimal degrees.

Latitude varies from −90° to 90°. The latitude of the Equator is 0°; the latitude of the South Pole is −90°; the latitude of the North Pole is 90°. Positive latitude values correspond to the geographic locations north of the Equator (abbrev. N). Negative latitude values correspond to the geographic locations south of the Equator (abbrev. S).

Longitude is counted from the prime meridian ( IERS Reference Meridian for WGS 84) and varies from −180° to 180°. Positive longitude values correspond to the geographic locations east of the prime meridian (abbrev. E). Negative longitude values correspond to the geographic locations west of the prime meridian (abbrev. W).

UTM or Universal Transverse Mercator coordinate system divides the Earth’s surface into 60 longitudinal zones. The coordinates of a location within each zone are defined as a planar coordinate pair related to the intersection of the equator and the zone’s central meridian, and measured in meters.

Elevation above sea level is a measure of a geographic location’s height. We are using the global digital elevation model GTOPO30 .

Elektrostal , Moscow Oblast, Russia